206 related articles for article (PubMed ID: 11734517)
1. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation.
Patel KA; Edmondson ND; Talbot F; Parsons MA; Rennie IG; Sisley K
Br J Ophthalmol; 2001 Dec; 85(12):1440-4. PubMed ID: 11734517
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics and prognosis for uveal melanoma in Korean patients.
Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
[TBL] [Abstract][Full Text] [Related]
3. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
[TBL] [Abstract][Full Text] [Related]
4. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.
Sisley K; Rennie IG; Parsons MA; Jacques R; Hammond DW; Bell SM; Potter AM; Rees RC
Genes Chromosomes Cancer; 1997 May; 19(1):22-8. PubMed ID: 9135991
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
7. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
[TBL] [Abstract][Full Text] [Related]
8. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
9. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of monosomy 3 in uveal melanoma.
Prescher G; Bornfeld N; Hirche H; Horsthemke B; Jöckel KH; Becher R
Lancet; 1996 May; 347(9010):1222-5. PubMed ID: 8622452
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chromogenic in situ hybridization for the determination of monosomy 3 in uveal melanoma.
Gleeson G; Larkin A; Horgan N; Kennedy S
Arch Pathol Lab Med; 2014 May; 138(5):664-70. PubMed ID: 24786124
[TBL] [Abstract][Full Text] [Related]
15. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.
Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M
Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812
[TBL] [Abstract][Full Text] [Related]
17. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
[TBL] [Abstract][Full Text] [Related]
18. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
19. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
20. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
